Doctors at UPMC have begun a study using an investigational cardiac device, the VentrAssist Left Ventricular Assist System (LVAD) to see whether it can be used safely and effectively in patients with end-stage heart failure.
Ads by Google
Physicians know that drug-eluting stents are an effective way to ensure that a patient's arteries will remain open after balloon angioplasty.
African American patients who undergo heart bypass surgery in high-volume hospitals have more benefit than white patients.
Patients who used the association's online heart disease education program were more aware of treatment options than Internet-using patients who did not use the association's program.
Knowing two important numbers - cholesterol and blood pressure - can help women evaluate their overall risk for heart disease and lead them on the path to healthier living.
One-year follow-up showed patients receiving stents off-label or untested faired similarly to patients who fit FDA criteria for standard use.
Cardiothoracic Surgeon Husam H. Balkhy was the first in the United States to use the C-Port(R) Flex A Anastomosis System, a fully-automated, flexible shaft device to attach a blood vessel graft during coronary artery bypass surgery.
Physicians should examine the risk factors before giving patients undergoing interventional heart procedures a combination of anti-blood clotting therapies.
ATS Medical acknowledged the positive clinical results of aortic root dimensions study presented by noted cardiologist Dr. Xu Yu Jin.
Ortho-Clinical Diagnostics has initiated a voluntary, nationwide recall of two lots of a diagnostic test used by physicians to aid in the diagnosis of injury to heart muscle and/or heart attack because of shifts in test results that could contribute to a missed diagnosis of myocardial infarction.
A naturally occurring molecule in the body appears to control whether certain medications, such as beta adrenergic receptor agonists used in acute heart failure or in inhalers for asthma, lose their effectiveness over time.
Lake Hospital System announced that it achieved zero percent mortality for all cardiac and major thoracic cases performed in 2006 through its Cleveland Clinic Heart Surgery Program at LakeWest Hospital.
A new study shows that aspirin therapy for coronary artery disease is four times more likely to be ineffective in women compared to men with the same medical history.
Response Biomedical Corporation is presenting data from two international studies at the Tenth Congress of Chest Pain Centers - The Chest Pain Center - A Team Approach in ACS Care.
The availability of a federally approved stent for aortic aneurysms in the upper chest is improving the quality of life for patients who otherwise would undergo a complicated open surgery or live a life of worry.
Annexin A5 Imaging offers opportunity to 'minimize' damage to Heart Muscle and may help in early identification of those individuals who are at risk of developing heart failure.
American Heart Association, American Dental Association introduce new guidelines.
Transplant leaders at Children's Hospital of Pittsburgh of UPMC are increasingly turning to an innovative procedure to make transplant surgery an option for young children with life-threatening heart failure.
Researchers have discovered that implantable cardioverter-defibrillators - electric monitoring devices that deliver a lifesaving shock in the event of a cardiac arrest - help patients with heart problems live longer more active lives.
Haptoglobin genotype identifies patients most likely to benefit from Alteon's investigational drug ALT-2074.
High consumption of trans fat, found mainly in partially hydrogenated vegetable oils and widely used by the food industry, has been linked to an increased risk of coronary heart disease (CHD).
Health Canada is informing Canadians that Permax, a drug used for the treatment of Parkinson's disease, has been withdrawn from the U.S. market amidst concerns about an association with cardiac valvulopathy, a condition involving inflammation or stiffening of the heart valves.
Heart attack patients who received an new intravenous adult stem cell therapy experienced a lower number of adverse events, such as cardiac arrhythmias.
Although anemia is a common problem in heart failure patients, the medications the patients take to control their heart failure are not the cause of the anemia.